What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Alzheimer's disease
His primary areas of investigation include Alzheimer's disease, Internal medicine, Dementia, Endocrinology and Apolipoprotein E.
His Alzheimer's disease research incorporates elements of Biomarker and Cognitive decline.
Internal medicine is closely attributed to Oncology in his research.
His Dementia study integrates concerns from other disciplines, such as Gerontology, Diabetes mellitus, Clinical psychology, Neuroscience and Amyloid.
His Endocrinology research focuses on subjects like Gene isoform, which are linked to High cholesterol, Guinea pig, Cavia and Regulation of gene expression.
Ralph N. Martins has researched Apolipoprotein E in several fields, including Apolipoprotein B, Immunology, Allele, Lipoprotein and Degenerative disease.
His most cited work include:
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer’s Disease (2062 citations)
- Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. (1210 citations)
- Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. (908 citations)
What are the main themes of his work throughout his whole career to date?
Ralph N. Martins mainly focuses on Internal medicine, Disease, Alzheimer's disease, Endocrinology and Dementia.
His Oncology research extends to the thematically linked field of Internal medicine.
His work deals with themes such as Clinical trial, Bioinformatics, Neuroscience and Ageing, which intersect with Disease.
His Alzheimer's disease research includes elements of Biomarker, Prospective cohort study and Immunology, Pathogenesis.
The study incorporates disciplines such as Psychiatry, Neuroimaging and Neuropsychology in addition to Dementia.
The various areas that Ralph N. Martins examines in his Cognitive decline study include Cognition and Gerontology.
He most often published in these fields:
- Internal medicine (50.37%)
- Disease (48.62%)
- Alzheimer's disease (36.74%)
What were the highlights of his more recent work (between 2018-2021)?
- Disease (48.62%)
- Internal medicine (50.37%)
- Cognition (24.86%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Disease, Internal medicine, Cognition, Dementia and Endocrinology.
Ralph N. Martins combines subjects such as Cerebrospinal fluid, Neuroscience, Gerontology and Bioinformatics with his study of Disease.
In his study, Neurology is strongly linked to Oncology, which falls under the umbrella field of Internal medicine.
Ralph N. Martins has included themes like Neuropathology, Neuropsychology and Confidence interval in his Dementia study.
His research investigates the connection between Endocrinology and topics such as Neurodegeneration that intersect with problems in Hippocampus.
His biological study focuses on Clinical Dementia Rating.
Between 2018 and 2021, his most popular works were:
- Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease (238 citations)
- Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need (88 citations)
- A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease. (75 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Disease
Disease, Alzheimer's disease, Internal medicine, Cognition and Cognitive decline are his primary areas of study.
His work in Dementia and Apolipoprotein E are all subfields of Disease research.
His Alzheimer's disease study combines topics in areas such as Biomarker, Cerebrospinal fluid, Pathogenesis and Stroke.
His research integrates issues of Strength training, Endocrinology and Oncology in his study of Internal medicine.
Ralph N. Martins combines subjects such as Cognitive health, Gerontology, Audiology and Intervention studies with his study of Cognition.
His research in Cognitive decline intersects with topics in Memory disorder, Homocysteine, Clinical trial, Randomized controlled trial and Ageing.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
